Drug Profile
Research programme: cancer therapeutics - Il Dong Pharmaceuticals
Alternative Names: Hyrubicin; ID-6105Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Il Dong
- Class Anthracyclines
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in South Korea (IV)